These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21147189)

  • 1. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
    Zhang L; Jilg N; Shao RX; Lin W; Fusco DN; Zhao H; Goto K; Peng LF; Chen WC; Chung RT
    J Hepatol; 2011 Aug; 55(2):289-98. PubMed ID: 21147189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
    Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
    PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
    Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
    Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
    Poat B; Hazari S; Chandra PK; Gunduz F; Alvarez X; Balart LA; Garry RF; Dash S
    Virol J; 2010 Oct; 7():265. PubMed ID: 20939906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.
    Zhu H; Butera M; Nelson DR; Liu C
    Virol J; 2005 Sep; 2():80. PubMed ID: 16146571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
    Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
    Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
    Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
    Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV NS5A and IRF9 compete for CypA binding.
    Bobardt M; Hopkins S; Baugh J; Chatterji U; Hernandez F; Hiscott J; Sluder A; Lin K; Gallay PA
    J Hepatol; 2013 Jan; 58(1):16-23. PubMed ID: 22902549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.
    Chen Y; Jiao B; Yao M; Shi X; Zheng Z; Li S; Chen L
    Virus Res; 2017 Jan; 227():231-239. PubMed ID: 27777077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.
    Yin Y; Romero N; Favoreel HW
    J Virol; 2021 Sep; 95(20):e0079321. PubMed ID: 34379505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.
    Lin W; Zhu C; Hong J; Zhao L; Jilg N; Fusco DN; Schaefer EA; Brisac C; Liu X; Peng LF; Xu Q; Chung RT
    J Hepatol; 2015 May; 62(5):1024-32. PubMed ID: 25481564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon.
    Hazari S; Taylor L; Haque S; Garry RF; Florman S; Luftig R; Regenstein F; Dash S
    Virol J; 2007 Sep; 4():89. PubMed ID: 17877826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
    Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
    Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway.
    Zhang Q; Gong R; Qu J; Zhou Y; Liu W; Chen M; Liu Y; Zhu Y; Wu J
    J Virol; 2012 Feb; 86(3):1544-54. PubMed ID: 22114332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.